Chanita Hughes-Halbert named associate director for cancer equity at USC Norris

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Chanita Hughes-Halbert was named director for cancer equity at University of Southern California Norris Comprehensive Cancer Center, and professor and vice chair of research in the Department of Preventive Medicine at Keck School of Medicine. 

Her appointment begins July 1, 2021.

Hughes-Halbert will join USC from the Medical University of South Carolina, where she is a professor of psychiatry and behavioral sciences, co-leader of the Cancer Control Program, holder of the AT&T Distinguished Endowed Chair at the Hollings Cancer Center and associate dean for assessment, evaluation and quality improvement at the College of Medicine.

Her work is focused on reducing the disparities in cancer outcomes that affect patients from underrepresented communities, with a primary focus on African American communities.

Hughes-Halbert has identified sociocultural, psychological, genetic and environmental determinants of cancer health disparities and translates this information into interventions to improve health equity among racially and ethnically diverse populations, as well as other medically underserved groups. 

Hughes-Halbert was elected to the National Academy of Medicine in 2017. 

At her current post, Hughes-Halbert directs the Transdisciplinary Collaborative Center in Precision Medicine and Minority Men’s Health. This program aims to develop medical strategies for minority men that are tailored to the specific social, genetic and environmental factors affecting each person’s health, with a focus on cancer.

President Barack Obama appointed Hughes-Halbert to NCI’s Board of Scientific Advisors in 2012, and in 2014 she joined the National Advisory Council of the National Human Genome Research Institute. 

Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login